Transgene (France) Probability of Future Stock Price Finishing Under 2.01
| TNG Stock | EUR 0.73 0.04 5.19% |
Transgene |
Transgene Target Price Odds to finish below 2.01
The tendency of Transgene Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under € 2.01 after 90 days |
| 0.73 | 90 days | 2.01 | close to 99 |
Based on a normal probability distribution, the odds of Transgene to stay under € 2.01 after 90 days from now is close to 99 (This Transgene SA probability density function shows the probability of Transgene Stock to fall within a particular range of prices over 90 days) . Probability of Transgene SA price to stay between its current price of € 0.73 and € 2.01 at the end of the 90-day period is about 89.74 .
Assuming the 90 days trading horizon Transgene SA has a beta of -0.18. This usually implies as returns on the benchmark increase, returns on holding Transgene are expected to decrease at a much lower rate. During a bear market, however, Transgene SA is likely to outperform the market. Additionally Transgene SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Transgene Price Density |
| Price |
Predictive Modules for Transgene
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Transgene SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Transgene Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Transgene is not an exception. The market had few large corrections towards the Transgene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Transgene SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Transgene within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.51 | |
β | Beta against Dow Jones | -0.18 | |
σ | Overall volatility | 0.15 | |
Ir | Information ratio | -0.18 |
Transgene Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Transgene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Transgene SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Transgene SA generated a negative expected return over the last 90 days | |
| Transgene SA has some characteristics of a very speculative penny stock | |
| Transgene SA has high historical volatility and very poor performance | |
| Transgene SA has a very high chance of going through financial distress in the upcoming years | |
| Transgene SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 9.99 M. Net Loss for the year was (19.54 M) with loss before overhead, payroll, taxes, and interest of (15.87 M). | |
| Transgene SA has accumulated about 16.9 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. |
Transgene Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Transgene Stock often depends not only on the future outlook of the current and potential Transgene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Transgene's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 83.8 M | |
| Cash And Short Term Investments | 49.6 M |
Transgene Technical Analysis
Transgene's future price can be derived by breaking down and analyzing its technical indicators over time. Transgene Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Transgene SA. In general, you should focus on analyzing Transgene Stock price patterns and their correlations with different microeconomic environments and drivers.
Transgene Predictive Forecast Models
Transgene's time-series forecasting models is one of many Transgene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Transgene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Transgene SA
Checking the ongoing alerts about Transgene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Transgene SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Transgene SA generated a negative expected return over the last 90 days | |
| Transgene SA has some characteristics of a very speculative penny stock | |
| Transgene SA has high historical volatility and very poor performance | |
| Transgene SA has a very high chance of going through financial distress in the upcoming years | |
| Transgene SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 9.99 M. Net Loss for the year was (19.54 M) with loss before overhead, payroll, taxes, and interest of (15.87 M). | |
| Transgene SA has accumulated about 16.9 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. |
Other Information on Investing in Transgene Stock
Transgene financial ratios help investors to determine whether Transgene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.